Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Ritha, Njau"'
Autor:
Eric Rogier, Nastassia Battle, Catherine Bakari, Misago D. Seth, Douglas Nace, Camelia Herman, Achut Barakoti, Rashid A. Madebe, Celine I. Mandara, Beatus M. Lyimo, David J. Giesbrecht, Zachary R. Popkin-Hall, Filbert Francis, Daniel Mbwambo, Issa Garimo, Sijenunu Aaron, Abdallah Lusasi, Fabrizio Molteni, Ritha Njau, Jane A. Cunningham, Samwel Lazaro, Ally Mohamed, Jonathan J. Juliano, Jeffrey A. Bailey, Venkatachalam Udhayakumar, Deus S. Ishengoma
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Plasmodium falciparum with the histidine rich protein 2 gene (pfhrp2) deleted from its genome can escape diagnosis by HRP2-based rapid diagnostic tests (HRP2-RDTs). The World Health Organization (WHO) recommends switching to a non-HRP2 RDT f
Externí odkaz:
https://doaj.org/article/d92f31d7cdc04d58bd7d693c2fc892ca
Autor:
Billy Ngasala, Mercy G. Chiduo, Samwel Bushukatale, Bruno P. Mmbando, Twilumba Makene, Erasmus Kamugisha, Maimuna Ahmed, Celine I. Mandara, Filbert Francis, Muhidin K. Mahende, Reginald A. Kavishe, Florida Muro, Deus S. Ishengoma, Renata Mandike, Fabrizio Molteni, Frank Chacky, Chonge Kitojo, George Greer, Dunstan Bishanga, Jasmine Chadewa, Ritha Njau, Marian Warsame, Bilali Kabula, Ssanyu S. Nyinondi, Erik Reaves, Ally Mohamed
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background The use of artemisinin-based combination therapy (ACT) is recommended by the World Health Organization for the treatment of uncomplicated falciparum malaria. Artemether-lumefantrine (AL) is the most widely adopted first-line ACT f
Externí odkaz:
https://doaj.org/article/362a297cf2994c71b915f580c1f2fc9c
Autor:
Deus S. Ishengoma, Celine I. Mandara, Rashid A. Madebe, Marian Warsame, Billy Ngasala, Abdunoor M. Kabanywanyi, Muhidin K. Mahende, Erasmus Kamugisha, Reginald A. Kavishe, Florida Muro, Renata Mandike, Sigsbert Mkude, Frank Chacky, Ritha Njau, Troy Martin, Ally Mohamed, Jeffrey A. Bailey, Abebe A. Fola
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-15 (2024)
Abstract Background Tanzania is currently implementing therapeutic efficacy studies (TES) in areas of varying malaria transmission intensities as per the World Health Organization (WHO) recommendations. In TES, distinguishing reinfection from recrude
Externí odkaz:
https://doaj.org/article/26bafc414ad743c8a6f8e21d86be9a4a
Autor:
Edwin A. Liheluka, Isolide S. Massawe, Mercy G. Chiduo, Celine I. Mandara, Frank Chacky, Leah Ndekuka, Filbert F. Temba, Bruno P. Mmbando, Misago D. Seth, Daniel P. Challe, Williams H. Makunde, Athanas D. Mhina, Vito Baraka, Method D. Segeja, Yahya A. Derua, Bernard M. Batengana, Paul M. Hayuma, Rashid A. Madebe, Masunga C. Malimi, Renata Mandike, Sigsbert Mkude, Fabrizio Molteni, Ritha Njau, Ally Mohamed, Susan F. Rumisha, Deus S. Ishengoma
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-16 (2023)
Abstract Background Despite significant decline in the past two decades, malaria is still a major public health concern in Tanzania; with over 93% of the population still at risk. Community knowledge, attitudes and practices (KAP), and beliefs are ke
Externí odkaz:
https://doaj.org/article/c424ebfa135245bda7bd2b7c4b952a44
Autor:
Eric Rogier, Catherine Bakari, Celine I. Mandara, Mercy G. Chiduo, Mateusz Plucinski, Douglas Nace, Nastassia Battle, Franky Chacky, Susan F. Rumisha, Fabrizio Molteni, Renata Mandike, Sigsbert Mkude, Ritha Njau, Ally Mohamed, Venkatachalam Udhayakumar, Deus S. Ishengoma
Publikováno v:
Malaria Journal, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background Malaria rapid diagnostic tests (RDTs) based on the detection of the Plasmodium falciparum histidine-rich protein 2 (HRP2) antigen are widely used for detection of active infection with this parasite and are the only practical mala
Externí odkaz:
https://doaj.org/article/10fbc7597b22413d84f5d0f1634faaeb
Autor:
Beatus M. Lyimo, Zachary R. Popkin-Hall, David J. Giesbrecht, Celine I. Mandara, Rashid A. Madebe, Catherine Bakari, Dativa Pereus, Misago D. Seth, Ramadhan M. Ngamba, Ruth B. Mbwambo, Bronwyn MacInnis, Daniel Mbwambo, Issa Garimo, Frank Chacky, Sijenunu Aaron, Abdallah Lusasi, Fabrizio Molteni, Ritha Njau, Jane A. Cunningham, Samwel Lazaro, Ally Mohamed, Jonathan J. Juliano, Jeffrey A. Bailey, Deus S. Ishengoma
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)
Recent developments in molecular biology and genomics have revolutionized biology and medicine mainly in the developed world. The application of next generation sequencing (NGS) and CRISPR-Cas tools is now poised to support endemic countries in the d
Externí odkaz:
https://doaj.org/article/70348c047f974cd98909f7207a091fdc
Autor:
Catherine Bakari, Sophie Jones, Gireesh Subramaniam, Celine I. Mandara, Mercy G. Chiduo, Susan Rumisha, Frank Chacky, Fabrizio Molteni, Renata Mandike, Sigsbert Mkude, Ritha Njau, Camelia Herman, Douglas P. Nace, Ally Mohamed, Venkatachalam Udhayakumar, Caleb K. Kibet, Steven G. Nyanjom, Eric Rogier, Deus S. Ishengoma
Publikováno v:
Malaria Journal, Vol 19, Iss 1, Pp 1-12 (2020)
Abstract Background Histidine-rich protein 2 (HRP2)-based malaria rapid diagnostic tests (RDTs) are effective and widely used for the detection of wild-type Plasmodium falciparum infections. Although recent studies have reported false negative HRP2 R
Externí odkaz:
https://doaj.org/article/b241218598884c6eb3dfabea46450b5a
Autor:
Deus S. Ishengoma, Celine I. Mandara, Filbert Francis, Eldin Talundzic, Naomi W. Lucchi, Billy Ngasala, Abdunoor M. Kabanywanyi, Muhidin K. Mahende, Erasmus Kamugisha, Reginald A. Kavishe, Florida Muro, Ally Mohamed, Renata Mandike, Sigsbert Mkude, Frank Chacky, Lynn Paxton, George Greer, Chonge A. Kitojo, Ritha Njau, Troy Martin, Meera Venkatesan, Marian Warsame, Eric S. Halsey, Venkatachalam Udhayakumar
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-13 (2019)
Abstract Background The World Health Organization recommends regular therapeutic efficacy studies (TES) to monitor the performance of first and second-line anti-malarials. In 2016, efficacy and safety of artemether-lumefantrine (AL) for the treatment
Externí odkaz:
https://doaj.org/article/72516af8e88547419f57e134211ba376
Autor:
Celine I. Mandara, Filbert Francis, Mercy G. Chiduo, Billy Ngasala, Renata Mandike, Sigsbert Mkude, Frank Chacky, Fabrizio Molteni, Ritha Njau, Ally Mohamed, Marian Warsame, Deus S. Ishengoma
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-12 (2019)
Abstract Background The Tanzanian National Malaria Control Programme (NMCP) and its partners have been implementing regular therapeutic efficacy studies (TES) to monitor the performance of different drugs used or with potential use in Tanzania. Howev
Externí odkaz:
https://doaj.org/article/67c4f5884e6d41d9badb49778eb7c00c
Autor:
Mwaka A. Kakolwa, Muhidin K. Mahende, Deus S. Ishengoma, Celine I. Mandara, Billy Ngasala, Erasmus Kamugisha, Johannes B. Kataraihya, Renata Mandike, Sigsbert Mkude, Frank Chacky, Ritha Njau, Zul Premji, Martha M. Lemnge, Marian Warsame, Didier Menard, Abdunoor M. Kabanywanyi
Publikováno v:
Malaria Journal, Vol 17, Iss 1, Pp 1-10 (2018)
Abstract Background Artemisinin-based combination therapy (ACT) is the first-line anti-malarial treatment of uncomplicated malaria in most malaria endemic countries, including Tanzania. Unfortunately, there have been reports of artemisinin resistance
Externí odkaz:
https://doaj.org/article/ee9da9dfdea34557ac4cebb6d5599354